Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma

Michela Giuliano1, Ornella Pellerito, Patrizia Portanova

  • 1Dipartimento di Scienze Biochimiche, Università di Palermo, Via del Vespro 129, 90127 Palermo, Italy.

Biochimie
|December 9, 2008
PubMed

Insights

Cannabinoids like WIN 55,212-2 induce apoptosis in liver cancer cells by activating specific pathways. This research suggests a potential therapeutic role for cannabinoids in treating hepatic cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cannabinoids are known to inhibit tumor cell growth and induce apoptosis.
  • Understanding the specific mechanisms and pathways involved is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the effects of WIN 55,212-2, a cannabinoid receptor agonist, on hepatoma HepG2 cells.
  • To elucidate the signal transduction pathway mediating WIN 55,212-2-induced apoptosis.

Main Methods:

  • Treatment of HepG2 cells with WIN 55,212-2.
  • Analysis of apoptosis-related gene and protein expression (Bax, Bcl-X(S), t-Bid, survivin, Bcl-2).
  • Assessment of JNK/p38 MAPK pathway activation, mitochondrial membrane potential, and PPARgamma levels.
  • Use of PPARgamma antagonists (GW9662, T0070907) to evaluate pathway involvement.

Main Results:

  • WIN 55,212-2 induced apoptosis in HepG2 cells, altering expression of pro-apoptotic and anti-apoptotic factors.
  • Apoptosis was linked to JNK/p38 MAPK activation and mitochondrial depolarization.
  • WIN 55,212-2 increased PPARgamma levels in a dose- and time-dependent manner.
  • PPARgamma antagonists significantly inhibited WIN 55,212-2's effects on cell viability and key signaling molecules.

Conclusions:

  • WIN 55,212-2 triggers apoptosis in hepatoma cells through the activation of the JNK/p38 MAPK pathway.
  • PPARgamma plays a critical role in mediating WIN 55,212-2-induced apoptosis in HepG2 cells.
  • These findings suggest a potential therapeutic application of WIN 55,212-2 in hepatic cancer treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...